Pictet Asset Management (Switzerland)’s Royalty Pharma RPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | $21.7M | Buy |
706,952
+128,674
| +22% | +$3.96M | 0.03% | 442 |
|
|
2023
Q1 | $20.8M | Buy |
578,278
+363,524
| +169% | +$13.1M | 0.03% | 445 |
|
|
2022
Q4 | $8.49M | Buy |
214,754
+23,498
| +12% | +$929K | 0.01% | 624 |
|
|
2022
Q3 | $7.69M | Buy |
191,256
+75,538
| +65% | +$3.04M | 0.01% | 637 |
|
|
2022
Q2 | $4.87M | Sell |
115,718
-1,675
| -1% | -$70.4K | 0.01% | 753 |
|
|
2022
Q1 | $4.57M | Buy |
117,393
+1,775
| +2% | +$69.2K | 0.01% | 822 |
|
|
2021
Q4 | $4.61M | Buy |
115,618
+55,753
| +93% | +$2.22M | ﹤0.01% | 845 |
|
|
2021
Q3 | $2.16M | Buy |
+59,865
| New | +$2.16M | ﹤0.01% | 982 |
|